Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Metformin

SKU: orb1298860

Description

Metformin

Research Area

Product Categories/Products/Small Molecules,Autophagy|||Chromatin/Epigenetic|||PI3K/Akt/mTOR signaling

Images & Validation

Key Properties

CAS Number657-24-9
MW129.16
Purity99.74%
FormulaC4H12ClN5
SMILESCN(C)C(=N)NC(N)=N

Bioactivity

Target IC50
TNF-α:3.35 μM|PANC1 cells viability:20.95 ± 0.98 mM|B-CPAP cells viability:5.329 mM|SARS-CoV-2 (Caco2 cells):1.43 mM|SARS-CoV-2 (Calu3 cells):0.4 mM
In Vivo
METHODS: To model Metformin-induced diarrhea, Metformin (125-500 mg/kg) was administered orally to healthy and diabetic obese db/db C57BL/6J mice twice daily for thirteen days. RESULTS: Metformin at 1000 mg/kg/day significantly increased fecal water content. Although no diarrhea symptoms were observed in healthy C57BL/6J mice, the same dose of Metformin induced severe diarrhea in diabetic obese db/db mice. METHODS: To investigate the protective effect of Metformin in radiation injury, Metformin (200 mg/kg once daily for three days) was administered orally to BALB/c mice, which were then exposed to 6-8 Gy of gamma radiation. RESULTS: When administered prior to exposure to radiation, Metformin prolonged the survival of mice exposed to 8 Gy-TBI and increased the survival of mice exposed to 6 Gy-TBI. Pretreatment with Metformin attenuated radiation damage.
In Vitro
METHODS: Ovarian cancer cells A2780 and SKOV3 were treated with Metformin (0.001-50 mM) for 24-48 h. Cell viability was assayed using the MTS RESULTS: Micromolar concentrations of Metformin did not statistically reduce the viability of the A2780 or SKOV3 cell lines. At 48 h, millimolar concentrations resulted in cell death. METHODS: Human colorectal cancer cells HCT29 were treated with Metformin (0.6 mM) for 90 h. Cell motility was detected using the wound healing assay and chamber invasion assay. RESULTS: Metformin inhibited the migration and invasion of HCT29 cells, and Metformin decreased the motility of tumor cells.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Metformin HCl(Glucophage) [orb134323]

    [1115-70-4]

    165.625

    C4H12ClN5

    1 g
  • Metformin Hydrochloride [orb1713844]

    ≥97%

    1115-70-4

    165.6

    C4H11N5•HCl

    5 g
  • DAPAGLIFLOZIN [orb180837]

    [461432-26-8]

    408.87

    C21H25ClO6

    1 g, 100 mg, 250 mg, 1 ml x 10 mm (in DMSO)
  • Metformin HCl [orb1101301]

    > =98%

    1115-70-4

    165.62

    C4H11N5.HCl

    1 g, 20 mg
  • Sitagliptin (Metformin,MK-0431) [orb146262]

    [486460-32-6]

    407.31

    C16H15F6N5O

    1 g, 100 mg, 250 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

10 mg
$ 140.00
1 ml x 10 mm (in DMSO)
$ 140.00
25 mg
$ 170.00
50 mg
$ 190.00
100 mg
$ 210.00
500 mg
$ 380.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry